NCT03381586COMPLETEDanonymous

QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803

Sponsor

Source record

Altor BioScience

Phase

Source record

PHASE 1

Modality

AI-normalized

small molecule

Target

AI-normalized

ALT-803

Indication / condition

AI-normalized

Healthy

Intervention

Source record

ALT-803

Related intelligence directories

Indication directory: Healthy Modality directory: small molecule Target directory: ALT-803

Source & freshness

Source record

NCT ID

NCT03381586

Original source

ClinicalTrials.gov

Source last updated

Mar 24, 2025

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT03381586

Title

QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803

Sponsor

Altor BioScience

Status

COMPLETED

Phase

PHASE 1

Condition raw

Healthy

Condition normalized

Healthy

Modality raw

Healthy

Modality normalized

small molecule

Target raw

ALT-803

Target normalized

ALT-803

Interventions

ALT-803

Public preview

Source record

This study, conducted by Altor BioScience, evaluated the pharmacokinetics of ALT-803, a drug administered subcutaneously to healthy volunteers. The trial aimed to understand the drug's absorption, distribution, metabolism, and excretion characteristics.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 20, 2026

NCT ID

NCT03381586

Status

COMPLETED

Phase

PHASE 1

Sponsor

Altor BioScience

Executive brief

Investment-Ready Snapshot

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedMar 24, 2025

Internal syncJun 05, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT03381586

Indication

Healthy

Modality

small molecule

Target

ALT-803

Intervention

ALT-803

Source record